The impact of trips-driven data exclusivity on pharmaceutical innovation in india: balancing patent and public health

HIGHLIGHTS

  • What: This research investigates these ramifications via the lenses of industry public health and trade compliance. This research investigates the origins of data exclusivity, its significance, and its relationship to Indian intellectual property laws. The literature study focusses on the increasing debate over patents and their perceived role in promoting innovation against perpetuating monopolistic behaviours. The Article explores the history of data exclusivity as a regulatory instrument, its integration into international accords such as the TRIPS Agreement, and ongoing arguments about its impact on medicine prices and accessibility.
  • Who: Dell from the school of law . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?